InsiderClue
Stocks · Health care · Pharmaceutical Preparations

SUPERNUS PHARMACEUTICALS, INC.

SUPN Clue Score33
United States Fiscal year ends December CIK 0001356576 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Georges Gemayel
23 Feb 2026
Director
Exercised, kept
15,000
$12.98
$194.70K
Frederick M. Hudson
9 Jan 2026
Director
Exercised, kept
15,000
$12.98
$194.70K
Charles W Newhall III
21 Nov 2025
Director
Exercised, kept
15,000
$12.98
$194.70K
Frederick M. Hudson
22 Jan 2025
Director
Exercised, kept
20,000
$9.13
$182.60K
Frederick M. Hudson
10 Jan 2023
Director
Exercised, kept
8,722
$7.90
$68.90K
Charles W Newhall III
28 Dec 2022
Director
Exercised, kept
8,722
$7.90
$68.90K
John M Siebert
11 Aug 2021
Director
Exercised, kept
15,000
$12.98
$194.70K
John M Siebert
20 Jun 2019
Director
Exercised, kept
10,000
$9.13
$91.30K
John M Siebert
25 Apr 2019
Director
Exercised, kept
10,000
$9.13
$91.30K
John M Siebert
20 Aug 2018
Director
Exercised, kept
7,457
$9.24
$68.90K
John M Siebert
20 Aug 2018
Director
Exercised, kept
8,722
$7.90
$68.90K
Show all 165 transactions →

What was left out

Form 4 filings counted 394
Amendments (4/A) skipped 12
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 124
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 6,560,609
Sales filed before the plan box existed 11
History held since 7 May 2012